Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed May 9, 2025

Accession no.
0001628280-25-024346
Filed
May 9, 2025
Trade date
Apr 1-30, 2025
Filing delay
38 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.64K. It was filed 38 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2025Common StockPPurchaseAcquired+45$4.24+$190.8283,763Direct
Apr 2, 2025Common StockPPurchaseAcquired+45$4.39+$197.55283,808Direct
Apr 3, 2025Common StockPPurchaseAcquired+45$4.21+$189.45283,853Direct
Apr 4, 2025Common StockPPurchaseAcquired+45$4.23+$190.35283,898Direct
Apr 7, 2025Common StockPPurchaseAcquired+45$4.19+$188.55283,943Direct
Apr 8, 2025Common StockPPurchaseAcquired+45$4.14+$186.3283,988Direct
Apr 9, 2025Common StockPPurchaseAcquired+45$4.09+$184.05284,033Direct
Apr 10, 2025Common StockPPurchaseAcquired+45$4.01+$180.45284,078Direct
Apr 11, 2025Common StockPPurchaseAcquired+45$4.02+$180.9284,123Direct
Apr 14, 2025Common StockPPurchaseAcquired+55$4.03+$221.65284,178Direct
Apr 15, 2025Common StockPPurchaseAcquired+55$4.14+$227.7284,233Direct
Apr 16, 2025Common StockPPurchaseAcquired+55$4.23+$232.65284,288Direct
Apr 17, 2025Common StockPPurchaseAcquired+55$4.61+$253.55284,343Direct
Apr 21, 2025Common StockPPurchaseAcquired+55$4.79+$263.45284,398Direct
Apr 22, 2025Common StockPPurchaseAcquired+55$4.74+$260.7284,453Direct
Apr 23, 2025Common StockPPurchaseAcquired+55$5.01+$275.55284,508Direct
Apr 24, 2025Common StockPPurchaseAcquired+55$5.12+$281.6284,563Direct
Apr 25, 2025Common StockPPurchaseAcquired+55$4.94+$271.7284,618Direct
Apr 28, 2025Common StockPPurchaseAcquired+45$4.91+$220.95284,663Direct
Apr 29, 2025Common StockPPurchaseAcquired+45$4.93+$221.85284,708Direct
Apr 30, 2025Common StockPPurchaseAcquired+45$4.79+$215.55284,753Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)